J Korean Cancer Assoc.
1998 Jun;30(3):561-572.
Urinary Gonadotropin Fragment ( UGF ) Measurements , Its Efficacy in Patients with Gynecologic and Various Malignancies
- Affiliations
-
- 1Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea.
- 2Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Seoul, Korea.
- 3Triton Diagnostics, Alameda, California, USA.
- 4Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut, USA.
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Efficacy of Tumor Markers, CA 125, CA 15-3 and UGF in Differentiating Malignant from Benign Pelvic Tumors
- Tumor markers-UGF, CA125, LSA, NB/70K and SCC in gynecologic malignancies
- Response of Human Chorionic Gonadotropin to 6-D-Trp-Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Stimulation in the Culture Media of Normal Human Placenta of Different Gestational Ages
- The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy induced ovarian failure in patient with gynecological malignancies
- The impact of robotic surgery on gynecologic oncology
